# EDGAR Filing Document

**Accession Number:** 0001411057
**File Stem:** 0001683168-26-002734
**Filing Date:** 2026-4
**Character Count:** 3523
**Document Hash:** 08c41656a1a8aafcba43b114cdbb0344
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-002734.hdr.sgml**: 20260513

**ACCESSION NUMBER**: 0001683168-26-002734

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260408

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cannabis Bioscience International Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001411057
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 844901229
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 6201 BONHOMME ROAD
- **STREET 2:** SUITE 435S
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77036
- **BUSINESS PHONE:** 214-733-0868

**MAIL ADDRESS:**
- **STREET 1:** 6201 BONHOMME ROAD
- **STREET 2:** SUITE 435S
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHINA INFRASTRUCTURE CONSTRUCTION Corp
- **DATE OF NAME CHANGE:** 20090916

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIDELITY AVIATION CORP
- **DATE OF NAME CHANGE:** 20070829

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

6201 Bonhomme Road, Suite 435N

Houston, Texas 77036

April 8, 2026

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | Cannabis Bioscience International Holdings, Inc. |
|  | Offering Statement on Form 1-A |
|  | File No. 024-12731 |
|  | Filed on March 27, 2026 |

---

Ladies and Gentlemen:

By its letter of April 1, 2026, the Commission has advised us that it does not intend to review the referenced Offering Statement.

Pursuant to Rule 252(e) promulgated under the Securities Act of 1933, Cannabis Bioscience International Holdings, Inc. (the "Company") requests that the Commission issue an order qualifying the Offering Statement, effective at 9:00 a.m., Eastern Time, on Monday, April 13, 2026, or as soon thereafter as practicable.

The Company acknowledges that:

&nbsp;&nbsp;&nbsp;&nbsp;· Should the requested order be issued, the resulting qualification will not foreclose the Commission from
taking any action with respect to the Offering Statement.

&nbsp;&nbsp;&nbsp;&nbsp;· The Company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.

&nbsp;&nbsp;&nbsp;&nbsp;· The Company may not assert the lack of comment by the staff on the Offering Statement or the qualification
of the Offering Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of
the United States.

&nbsp;&nbsp;&nbsp;&nbsp;· The Company is aware of its reporting requirements under Rule 257 of Regulation A.

There are no participants in the offering that are required to clear compensation arrangements with FINRA.

The Company requests that it be notified of the issuance of the order of qualification by telephone call or email to the undersigned at (214) 733-0868 / dpicazo@cbih.net or to its counsel, Barry J. Miller, at (248) 232-8039 / bjmiller@bjmpllc.com.

If you have any questions, please contact the above-named counsel.

Very truly yours,

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

---

| | |
|:---|:---|
| By: | /s/ Dante Picazo |
|  | Dante Picazo<br> Chief Executive Officer |

---